LAFFI, GIACOMO
 Distribuzione geografica
Continente #
NA - Nord America 21.583
EU - Europa 14.137
AS - Asia 7.980
SA - Sud America 939
AF - Africa 231
OC - Oceania 165
Continente sconosciuto - Info sul continente non disponibili 95
Totale 45.130
Nazione #
US - Stati Uniti d'America 21.274
RU - Federazione Russa 4.607
IT - Italia 2.534
SG - Singapore 2.216
PL - Polonia 2.043
CN - Cina 1.654
HK - Hong Kong 1.460
SE - Svezia 1.223
IE - Irlanda 1.136
VN - Vietnam 885
BR - Brasile 781
KR - Corea 752
DE - Germania 599
UA - Ucraina 555
FI - Finlandia 428
FR - Francia 387
GB - Regno Unito 288
IN - India 239
CA - Canada 200
JP - Giappone 194
AU - Australia 163
JO - Giordania 113
TR - Turchia 104
CH - Svizzera 87
BD - Bangladesh 85
NL - Olanda 69
CI - Costa d'Avorio 60
AR - Argentina 55
ID - Indonesia 50
BE - Belgio 43
MX - Messico 43
IQ - Iraq 42
NG - Nigeria 38
ES - Italia 33
ZA - Sudafrica 32
PK - Pakistan 28
EC - Ecuador 25
MA - Marocco 24
UZ - Uzbekistan 24
EG - Egitto 23
CO - Colombia 19
SC - Seychelles 18
VE - Venezuela 18
AE - Emirati Arabi Uniti 16
SA - Arabia Saudita 13
AZ - Azerbaigian 11
CL - Cile 11
PE - Perù 11
AL - Albania 10
AT - Austria 10
CR - Costa Rica 10
CZ - Repubblica Ceca 10
JM - Giamaica 10
PY - Paraguay 10
HN - Honduras 9
PH - Filippine 9
BG - Bulgaria 8
DZ - Algeria 8
KE - Kenya 8
MY - Malesia 8
PT - Portogallo 8
TH - Thailandia 7
TN - Tunisia 7
TT - Trinidad e Tobago 7
KZ - Kazakistan 6
LT - Lituania 6
LV - Lettonia 6
NP - Nepal 6
RO - Romania 6
SY - Repubblica araba siriana 6
DK - Danimarca 5
GT - Guatemala 5
HU - Ungheria 5
IL - Israele 5
KG - Kirghizistan 5
OM - Oman 5
PA - Panama 5
SV - El Salvador 5
TW - Taiwan 5
UY - Uruguay 5
AM - Armenia 4
BO - Bolivia 4
BY - Bielorussia 4
LB - Libano 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
BB - Barbados 3
DO - Repubblica Dominicana 3
EE - Estonia 3
GR - Grecia 3
KH - Cambogia 3
LA - Repubblica Popolare Democratica del Laos 3
MT - Malta 3
NI - Nicaragua 3
NO - Norvegia 3
PS - Palestinian Territory 3
RS - Serbia 3
BH - Bahrain 2
CY - Cipro 2
EU - Europa 2
Totale 45.001
Città #
Santa Clara 4.432
Ashburn 2.040
Warsaw 2.034
Fairfield 1.881
Singapore 1.511
Hong Kong 1.204
Chandler 1.190
Dublin 1.135
San Jose 917
Jacksonville 889
Woodbridge 838
Cambridge 776
Seattle 768
Seoul 746
Houston 651
Wilmington 642
Milan 571
Beijing 536
Los Angeles 390
Ann Arbor 369
Buffalo 317
Princeton 288
The Dalles 284
Ho Chi Minh City 265
Lauterbourg 241
Boston 231
Rome 223
Boardman 217
Hanoi 208
Lawrence 207
Altamura 203
Dallas 191
Tokyo 176
Melbourne 161
Florence 146
Hefei 145
Mumbai 131
Munich 126
Moscow 120
New York 115
Medford 111
San Diego 107
Helsinki 100
Shanghai 91
Bern 85
Paris 81
Bremen 69
Naples 68
Izmir 67
São Paulo 63
Turku 61
Abidjan 60
Council Bluffs 58
Norwalk 57
London 56
Kent 51
Turin 48
Bologna 47
Bari 44
Redondo Beach 44
Orem 43
Da Nang 42
Frankfurt am Main 42
Toronto 41
Montreal 39
Verona 38
Guangzhou 37
Abuja 36
Brussels 34
Haiphong 33
Dong Ket 32
Hillsboro 32
Palermo 31
Andover 30
Brooklyn 30
Jakarta 30
Chicago 29
Falls Church 28
Auburn Hills 26
Phoenix 26
Miano 24
Chennai 23
Tashkent 23
Figino 22
Salerno 22
Yubileyny 22
Stockholm 21
Washington 21
Belo Horizonte 20
Clifton 20
Dearborn 20
Rio de Janeiro 20
Atlanta 19
Hải Dương 19
Manchester 19
Biên Hòa 18
Genoa 18
Tianjin 18
Venice 18
Cagliari 17
Totale 29.966
Nome #
Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis 372
Complete resolution of primary sclerosing peritonitis ("abdominalCocoon") following long term therapy for tropheryma whipplei: a case report and review of literature. 367
Effect of some cyclooxygenase inhibitors on the increase in guanosine 3':5'-cyclic monophosphate induced by NO-donors in human whole platelets. 357
Acute on chronic liver failure: From pathophysiology to clinical management. 343
Macro-aspartate aminotransferase in a healthy woman 324
Evaluation of the prognostic value of liver stiffness in patients with hepatitis C virus treated with triple or dual antiviral therapy: A prospective pilot study 321
Differential expression of two isoforms of the chemokine receptor CXCR3 determines the ultimate effect of IP-10 on survival of human hepatic stellate cells (HSC) 320
Role of MicroRNA Profile Modifications in Hepatitis C Virus-Related Mixed Cryoglobulinemia 319
Nitrovasodilators inhibit platelet-derived growth factor-induced proliferation and migration of activated human hepatic stellate cells. 318
Aggressive gastric carcinoma producing alpha-fetoprotein: a case report and review of the literature. 316
Transjugular Intrahepatic Portosystemic Shunt does not affect the efficacy and safety of direct-acting antivirals in patients with advanced cirrhosis: A real-life, case-control study 308
Neuroendocrine dysregulation in irritable bowel syndrome patients: A pilot study 307
Assessment of liver stiffness in patients with HCV and mixed cryoglobulinemia undergoing rituximab treatment. 303
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 277
Aldoxorubicin and Temozolomide combination in a xenograft mice model of human glioblastoma. 277
Tumor response of temozolomide in combination with morphine in a xenograft model of human glioblastoma 273
Under-dilated TIPS Associate With Efficacy and Reduced Encephalopathy in a Prospective, Non-randomized Study of Patients With Cirrhosis 270
Platelet-activating factor mediates an autocrine proliferative loop in the endometrial adenocarcinoma cell line HEC-1A. 265
HCV Patients Psychopathology and Tryptophan Metabolism: Analysis of the Effects of Pegylated Interferon plus Ribavirin Treatment 259
D-dimer and fibrinolytic activity in patients with liver cirrhosis and ascites. Preliminary results. 248
The kinin system and other vasoactive substances in chronic liver disease. 242
[Renal function in chronic hepatopathies] 241
Acute viral hepatitis increases liver stiffness values measured by transient elastography 237
THE ACTIN CYTOSKELETON AS A NOVEL TARGET OF AMP-ACTIVATED PROTEIN KINASE (AMPK) IN HEPATIC STELLATE CELLS 232
[Some aspects of the physiopathology of renal insufficiency in the course of chronic liver diseases] 231
Interferon-free therapy in hepatitis C virus mixed cryoglobulinaemia: a prospective, controlled, clinical and quality of life analysis 231
Longitudinal assessment of liver stiffness in patients undergoing antiviral treatment for hepatitis C 226
Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells. 223
Effect of antiviral treatment in patients with chronic HCV infection and t(14;18) translocation 221
Reduced platelet thromboxane A2 production as a possible cause of defective platelet aggregation in cirrhosis. 220
Thrombopoietin stimulates migration and activates multiple signaling pathways in hepatoblastoma cells. 219
Altered clot formation and lysis are associated with increased fibrinolytic activity in ascites in patients with advanced cirrhosis 217
Association Between Persistent Lymphatic Infection By Hepatitis C Virus After Antiviral Treatment And Mixed Cryoglobulinemia 216
Adenosine monophosphate-activated protein kinase modulates the activated phenotype of hepatic stellate cells 212
Transjugular intrahepatic portosystemic shunt (TIPS): current indications and strategies to improve the outcomes 210
Effect of chronic hepatitis C virus infection on inflammatory lipid mediators 209
DRESS syndrome in a patient with chronic hepatic encephalopathy. 208
ADMA correlates with portal pressure in patients with compensated cirrhosis. 205
Prevention of severe toxic liver injury and oxidative stress in MCP-1-deficient mice 205
Host genetic determinants in HCV-related mixed cryoglobulinemia 205
Altered cardiovascular responsiveness to active tilting in nonalcoholic cirrhosis. 205
Long-term effect of HCV eradication in patients with mixed cryoglobulinemia: A prospective, controlled, open-label, cohort study. 204
Elevated plasma levels of urotensin II do not correlate with systemic haemodynamics in patients with cirrhosis. 202
Epidemiological, demographic and clinical data on chronic viral hepatitis C in Tuscany 201
Clinical epidemiology of chronic viral hepatitis B: A Tuscany real-word large-scale cohort study 201
Plasma levels of brain natriuretic peptide in patients with cirrhosis. 200
Host genetic determinants in HCV-related mixed cryoglobulinemia 198
THROMBOPOIETIN STIMULATES MIGRATION AND INVASION OF HepG2 CELLS. 196
Modifications of plasma platelet-activating factor (PAF)- acetylhydrolase/PAF system activity in patients with chronic hepatitis C virus infection 196
Ascites and hepatorenal syndrome during cirrhosis: two entities or the continuation of the same complication? 195
Renal hemodynamic and natriuretic effects of human atrial natriuretic factor infusion in cirrhosis with ascites. 194
Combined presence of HCVRNA sequences and t(14;18) (q32;q21) translocation in PBMC from patients with chronic HCV infection 192
Expression of IP-10 and its receptor CXCR3 in hepatic stellate cells identifies a novel autocrine and paracrine system. 192
Altered platelet function in cirrhosis of the liver: impairment of inositol lipid and arachidonic acid metabolism in response to agonists 192
Increased production of nitric oxide by neutrophils and monocytes from cirrhotic patients with ascites and hyperdynamic circulation. 191
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 191
Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial. 190
Analysis of HCV persistence in patients with sustained virological response 190
Non-invasive assessment of liver fibrosis in patients with HBV-related chronic liver disease undergoing antiviral treatment: A preliminary study 190
Altered furosemide pharmacokinetics in chronic alcoholic liver disease with ascites contributes to diuretic resistance 190
EFFECTS OF NITRIC OXIDE (NO)-DONORS ON ACTIVATED HUMAN HEPATIC STELLATE CELLS (HSC): CELLULAR BASIS FOR THE TREATMENT OF PORTAL HYPERTENSION. 189
Expression and function of integrin receptors for collagen and laminin in cultured human hepatic stellate cells. 188
Defective aggregation in cirrhosis is independent of in vivo platelet activation. 188
Long-term albumin infusion improves survival in patients with cirrhosis and ascites: an unblinded randomized trial. 187
Functional insufficiency in chronic liver disease patients. The hepatorenal syndrome 187
CD81 Modulation by Immobilized Monoclonal Antibodies is Able to Promote B-cell proliferation and C-MYC expression 187
Systemic hemodynamics and renal function in cirrhotic patients during plasma volume expansion. 185
Cardiovascular effects of canrenone in patients with preascitic cirrhosis 185
Cardiac and renal response to posture in cirrhotics with and without essential hypertension 185
COMBINED PRESENCE OF HCVRNA SEQUENCES AND T(14;18) (q32;q21) TRANSLOCATION IN PBMC FROM PATIENTS WITH CHRONIC HCV INFECTION. 185
Altered neuro-endocrine-immune pathways in the irritable bowel syndrome: the top-down and the bottom-up model. 184
Acute effect of furosemide on renal kallikrein and prostaglandin systems in mild to moderate essential hypertension. 183
[Hearing threshold of workers not exposed to occupational noise: reference values] 182
Longitudinal assessment of liver stiffness in patients undergoing antiviral treatment for hepatitis C. 182
Expression of the thrombin receptor in human liver: up-regulation during acute and chronic injury. 182
ALBUMIN IMPROVES RESPONSE TO DIURETICS IN DECOMPENSATED CIRRHOTIC PATIENTS. 181
Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial 181
Nuclear localization of TRK-A in liver cells. 180
Functional renal alterations in chronic liver diseases. 180
Triple antiviral therapy in hepatitis C virus infection with or without mixed cryoglobulinaemia: A prospective, controlled pilot study. 180
Increased plasma carbon monoxide in patients with viral cirrhosis and hyperdynamic circulation. 179
Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C 178
Screening of distress among hospitalized patients in a department of internal medicine. 178
Age-dependent association of exposure to television screen with children's urinary melatonin excretion? 178
Improvement in liver cirrhosis after treatment of HCV-related mixed cryoglobulinemia with rituximab 177
Safety and efficacy of rituximab in patients with hepatitis C virus-related mixed cryoglobulinemia and severe liver disease 176
HCV-related mixed cryoglobulinemia and BAFF promoter polymorphism 176
CD81 modulation by immobilized monoclonal antibodies is able to promote B-cell proliferation and c-myc expression 176
Adiponectin and the cardiovascular system: from risk to disease. 176
Low serum tryptophan levels, reduced macrophage IDO activity and high frequency of psychopathology in HCV patients 175
Can BAFF promoter polymorphism be a predisposing condition for HCV-related mixed cryoglobulinemia? 175
Agonist-specific regulation of monocyte chemoattractant protein-1 expression by cyclo-oxygenase metabolites in hepatic stellate cells 175
Loop diuretic therapy in liver cirrhosis with ascites 174
Ascites and hepatorenal syndrome during cirrhosis: two entities or the continuation of the same complication? 173
Predictors of survival in patients with established cirrhosis and hepatocellular carcinoma treated with sorafenib 173
microRNA PROFILE MODIFICATIONS IN HEPATITIS C VIRUS-RELATED MIXED CRYOGLOBULINEMIA 173
Activation of focal adhesion kinase by PDGF is dependent on Ras in human hepatic stellate cells 172
CD81 MODULATION BY IMMOBILIZED MONOCLONAL ANTIBODIES IS ABLE TO PROMOTE B-CELL PROLIFERATION AND C-MYC EXPRESSION 172
Liver stiffness is influenced by a standardized meal in patients with chronic hepatitis C virus at different stages of fibrotic evolution. 172
Evidence for a storage pool defect in platelets from cirrhotic patients with defective aggregation 171
Totale 21.644
Categoria #
all - tutte 117.937
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 117.937


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.845 45 190 92 79 69 71 76 111 92 63 402 555
2022/20235.035 466 677 269 386 451 938 673 312 569 24 146 124
2023/20241.593 68 209 306 91 102 231 45 357 22 45 56 61
2024/202512.374 411 1.269 829 1.929 3.966 1.413 124 784 607 293 397 352
2025/202612.517 1.527 1.683 772 1.086 1.329 403 1.411 526 999 720 246 1.815
2026/2027375 375 0 0 0 0 0 0 0 0 0 0 0
Totale 45.130